Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcus Biosciences Inc RCUS

Healthcare Biotechnology
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical... see more

Recent & Breaking News (NYSE:RCUS)

Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-stage Programs and New Research Collaboration

Business Wire December 21, 2021

Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer

GlobeNewswire December 14, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire December 9, 2021

Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences' Anti-TIGIT Program in Japan and Certain Territories in Asia

Business Wire November 30, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire November 24, 2021

Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference

Business Wire November 22, 2021

Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration

Business Wire November 18, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire November 9, 2021

Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab

Business Wire November 8, 2021

Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights

Business Wire November 2, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire October 26, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire October 11, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire September 27, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire September 9, 2021

Arcus Biosciences to Participate at Upcoming Investor Conferences

Business Wire September 1, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire August 24, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire August 10, 2021

Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights

Business Wire August 5, 2021

Arcus Biosciences to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conference

Business Wire August 4, 2021

Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights

Business Wire July 29, 2021